Objectives: To describe the communication behaviors of patients and physicians and patient par-ticipation in communication about treatment decision-making during consultation visits for local-ized prostate cancer (LPC...Objectives: To describe the communication behaviors of patients and physicians and patient par-ticipation in communication about treatment decision-making during consultation visits for local-ized prostate cancer (LPCa). Methods: This is a secondary analysis of data from 52 men enrolled in the usual care control group of a randomized trial that focused on decision-making for newly diagnosed men with LPCa. We analyzed the patient-physician communication using the transcribed audio-recordings of real-time treatment consultations and a researcher-developed coding tool, including codes for communication behaviors (information giving, seeking, and clarifying/ verifying) and contents of clinical consultations (health histories, survival/mortality, treatment options, treatment impact, and treatment preferences). After qualitative content analysis, we categorized patient participation in communication about treatment-related clinical content, including “none” (content not discussed);“low” (patient listening only);“moderate” (patient providing information or asking questions);and “high” (patient providing information and asking questions). Results: Physicians mainly provided information during treatment decision consultations and patients frequently were not active participants in communication. The participation of patients with low and moderate cancer risk typically was: 1) “moderate and high” in discussing health histories;2) “low” in discussing survival/mortality;3) “low and moderate” in discussing treatment options;4) “none and low” in discussing treatment impacts;and 5) “low” in discussing treatment preferences. Conclusions: Findings suggest opportunities for increasing patient participation in communication about treatment decision-making for LPCa during clinical consultations.展开更多
Shared decision-making has been described as allowing patients to gain more control over their life situation and feel less helpless. The aim of this systematic review was to describe the involvement of older patients...Shared decision-making has been described as allowing patients to gain more control over their life situation and feel less helpless. The aim of this systematic review was to describe the involvement of older patients in shared decision-making in community settings. In accordance with the systematic review method, a total of 2468 abstracts were read, after which nine quantitative studies were included. A qualitative thematic analysis was performed and two themes emerged;increased understanding of self-management and a desire to strengthen one’s position in relationship with professionals, both of which were essential for empowering older patients to participate in shared decision-making. Older patients’ shared decision-making was seen as a struggle to maintain their autonomy in different areas of everyday life. Emotional and psychological problems made their position more difficult. In order to empower them in relationships with healthcare professionals, older patients require more knowledge (self-efficacy) and information about their illness, which could strengthen their position in the decision-making process. They also need a greater awareness of decisional conflicts that may arise. Age, gender and health status influence older patients’ chance of being respected and taken seriously in relationship with professionals.展开更多
The simulated patient methodology(SPM)is considered the“gold standard”as covert participatory observation.SPM is attracting increasing interest for the investigation of community pharmacy practice;however,there is c...The simulated patient methodology(SPM)is considered the“gold standard”as covert participatory observation.SPM is attracting increasing interest for the investigation of community pharmacy practice;however,there is criticism that SPM can only show a small picture of everyday pharmacy practice and therefore has limited external validity.On the one hand,a certain design and application of the SPM goes hand in hand with an increase in external validity.Even if,on the other hand,this occurs at the expense of internal validity due to the trade-off situation,the justified criticism of the SPM for investigating community pharmacy practice can be countered.展开更多
BACKGROUND There is a lack of studies and educational programs focused on biosimilars and shared decision-making among patients diagnosed with various rheumatic diseases.AIM To improve knowledge and awareness of biosi...BACKGROUND There is a lack of studies and educational programs focused on biosimilars and shared decision-making among patients diagnosed with various rheumatic diseases.AIM To improve knowledge and awareness of biosimilars and shared decision-making among patients attending rheumatology practices in Colorado as well as to assess a rheumatology patient’s interest in discussing biosimilars as well as shared decision-making with others(e.g.,medical professionals,family members,friends).METHODS Our goal was to work with 80 rheumatology teams in Colorado.We developed and distributed 2000 multi-page brochures to each participating office and later conducted an online anonymous survey.RESULTS There were a total of 49(2.5%)rheumatology patients who responded to our survey.After reading our educational booklet,many survey respondents identified the correct answer in most questions focused on biosimilars or shared decision-making.Our survey results suggest that patients attending rheumatology practices in Colorado are generally not involved in discussions with their providers regarding treatment plans or options.The improvement in scores after reading our educational materials was statistically significant for biosimilars and shared decision-making.CONCLUSION Overall,the level of knowledge and awareness of biosimilars and shared decisionmaking among patients attending rheumatology practices in Colorado was low.More educational programs as well as follow up trainings to measure changes in knowledge and awareness regarding biosimilars and shared decision-making among patients attending rheumatology practices are recommended.展开更多
This paper delves into the intricate interplay between artificial intelligence(AI)systems and the perpetuation of Anti-Black racism within the United States medical industry.Despite the promising potential of AI to en...This paper delves into the intricate interplay between artificial intelligence(AI)systems and the perpetuation of Anti-Black racism within the United States medical industry.Despite the promising potential of AI to enhance healthcare outcomes and reduce disparities,there is a growing concern that these technologies may inadvertently/advertently exacerbate existing racial inequalities.Focusing specifically on the experiences of Black patients,this research investigates how the following AI components:medical algorithms,machine learning,and natural learning processes are contributing to the unequal distribution of medical resources,diagnosis,and health care treatment of those classified as Black.Furthermore,this review employs a multidisciplinary approach,combining insights from computer science,medical ethics,and social justice theory to analyze the mechanisms through which AI systems may encode and reinforce racial biases.By dissecting the three primary components of AI,this paper aims to present a clear understanding of how these technologies work,how they intersect,and how they may inherently perpetuate harmful stereotypes resulting in negligent outcomes for Black patients.Furthermore,this paper explores the ethical implications of deploying AI in healthcare settings and calls for increased transparency,accountability,and diversity in the development and implementation of these technologies.Finally,it is important that I prefer the following paper with a clear and concise definition of what I refer to as Anti-Black racism throughout the text.Therefore,I assert the following:Anti-Black racism refers to prejudice,discrimination,or antagonism directed against individuals or communities of African descent based on their race.It involves the belief in the inherent superiority of one race over another and the systemic and institutional practices that perpetuate inequality and disadvantage for Black people.Furthermore,I proclaim that this form of racism can be manifested in various ways,such as unequal access to opportunities,resources,education,employment,and fair treatment within social,economic,and political systems.It is also pertinent to acknowledge that Anti-Black racism is deeply rooted in historical and societal structures throughout the U.S.borders and beyond,leading to systemic disadvantages and disparities that impact the well-being and life chances of Black individuals and communities.Addressing Anti-Black racism involves recognizing and challenging both individual attitudes and systemic structures that contribute to discrimination and inequality.Efforts to combat Anti-Black racism include promoting awareness,education,advocacy for policy changes,and fostering a culture of inclusivity and equality.展开更多
The value-chain approach(VCA)was used for exploring how a niche crop,namely large cardamom(Amomum subulatum Roxb.),can be developed sustainably to increase incomes and enhance rural livelihoods in the mountains.Large ...The value-chain approach(VCA)was used for exploring how a niche crop,namely large cardamom(Amomum subulatum Roxb.),can be developed sustainably to increase incomes and enhance rural livelihoods in the mountains.Large cardamom is a high-value,agro-climatically suitable,and non-perishable spice crop grown in the Himalayan region.Originating in Sikkim,the crop is important to the local economy and is sold in both domestic and international markets;however,its production in India has been declining significantly in recent years.Using VCA and participatory methods of data collection the study helped elicit value chain actors’perspectives on various reasons for the decline as well as potential strategies to improve the cardamom value chain.The results present the multiple environmental and climatic(e.g.water stress),social(e.g.women participation)and institutional(e.g.lack of trust between actors)challenges and corresponding upgrading strategies.Through participatory multi-criteria analysis(MCA),the strategies were prioritized based on the overall preferences of multiple stakeholders.The analysis considered eight criteria and 25 options,or strategies,and found that that marketability and profitability were the most important criteria,and increasing cardamom production,the most important optiontrait.Stakeholder discussions along with sensitivity analysis also showed how these options could be implemented and revealed how criteria preferences can change with expert inputs.This combination of VCA and MCA,because it supports participatory decision-making and balances multiple dimensions of sustainable development,can be effectively deployed in planning for agricultural development in the mountains.展开更多
目的探讨患者参与式全程营养管理对同期放化疗食管癌患者营养状态和毒副作用的影响。方法选择2021年2—7月在泰安市肿瘤防治院拟行同期放化疗的食管癌患者50例作为对照组,予以常规肿瘤患者营养指导;按照组间基本资料具有可比性的原则选...目的探讨患者参与式全程营养管理对同期放化疗食管癌患者营养状态和毒副作用的影响。方法选择2021年2—7月在泰安市肿瘤防治院拟行同期放化疗的食管癌患者50例作为对照组,予以常规肿瘤患者营养指导;按照组间基本资料具有可比性的原则选择2021年8月—2022年2月在泰安市肿瘤防治院行同期放化疗的食管癌患者50例作为观察组,予以患者参与式全程营养管理;两组均持续干预8周,对比两组患者行护理管理前后的营养状态[营养风险筛查表(2002)(NRS-2002)、患者主观全面评估(Scored Patient-Generated Subjective Global Assessment,PG-SGA)及相关血清蛋白指标]、癌性疲乏度[癌症疲乏量表(CFS)]、饮食依从性及放化疗毒副作用发生率。结果患者参与式全程营养管理后,两组营养不良风险发生率比较差异无统计学意义(P>0.05);观察组PG-SGA评分低于对照组,血清蛋白各项指标水平均高于对照组(P<0.05);观察组CFS评分低于对照组,能量及蛋白质摄入依从性评分均高于对照组(P<0.05)。两组患者的毒副作用发生率比较差异无统计学意义(P>0.05)。结论患者参与式全程式营养管理模式可有效改善患者的营养状况和癌性疲乏,提高患者的饮食依从性。展开更多
目的:探讨病人参与式护理下重组人表皮生长因子(recombinant human epidermal growth factor,rhEGF)结合银离子敷料治疗在降低骨折病人压力性损伤发生风险中的应用效果。方法:选取2021年1月—12月在我院治疗的198例骨折病人为研究对象,...目的:探讨病人参与式护理下重组人表皮生长因子(recombinant human epidermal growth factor,rhEGF)结合银离子敷料治疗在降低骨折病人压力性损伤发生风险中的应用效果。方法:选取2021年1月—12月在我院治疗的198例骨折病人为研究对象,采取随机数字表法将其分为对照组和观察组,各99例。两组均给予rhEGF结合银离子敷料治疗,对照组给予常规护理,观察组在对照组的基础上给予病人参与式护理模式。比较两组压力性损伤发生率、临床疗效、炎症情况及病人护理参与行为。结果:干预2个月后,观察组压力性损伤发生率(5.05%)低于对照组(13.13%),压力性损伤临床疗效优于对照组;肿瘤坏死因子、血清超敏C反应蛋白、白细胞介素-6和白细胞介素-8炎症因子水平低于对照组;参与行为量表总分[(67.24±6.21)分]高于对照组[(54.23±4.82)分],差异均有统计学意义(P<0.05)。结论:病人参与式护理可提高骨折病人在压力性损伤护理中的参与度,降低病人压力性损伤发生风险,缓解炎症反应,促进创面愈合。展开更多
In China,there are three basic clinical decision-making modes for patients,namely patients autonomous decision-making mode,family decision-making mode and patient and family codetermination.They were produced under th...In China,there are three basic clinical decision-making modes for patients,namely patients autonomous decision-making mode,family decision-making mode and patient and family codetermination.They were produced under the unique background of Chinese medicine,Confucian philosophy and law in China,l this paper,the concepts,advantages and disadvantages of these three decision-making modes were analyzed In addition,some suggestions were put forward for the improvement.The first is that we suggest to establis standards for choosing decision-making modes;the second is to further learn and publicize relevant laws;thirdly the legal system needs to be further refined;and the last one is to carry out ethical ward round.展开更多
The application of main methodologies for clinical decision-making by residents in emergency medical practice was assessed,and issues in this area were investigated.The treatments provided to 2611 critical patients by...The application of main methodologies for clinical decision-making by residents in emergency medical practice was assessed,and issues in this area were investigated.The treatments provided to 2611 critical patients by the Emergency Department of Peking Union Medical College Hospital were analyzed by independent investigators who evaluated the main clinical decision-making processes applied by the hospital residents.The application of decision-making strategies by PG1 and PG3 groups,which means the residents in first year and the third year,were compared.The patients were treated according to pattern recognition(43.0%),hypotheticodeductive reasoning(23.4%),event-driven models(19.3%),and rule-using algorithms(5.9%).A significant difference was found between PG1 and PG3 groups(χ^(2)=498.01,P<0.001).Pattern recognition and hypotheticdeductive methods were the most common techniques applied by emergency physicians in evaluating critically ill patients.The decision-making processes applied by junior and senior residents were significantly different,although neither group adequately applied rule-using algorithms.Inclusion of clinical decision-making in medical curricula is needed to improve decision-making in critical care.展开更多
Medical treatment of patients inherently entails the risk of undesired complication or side effects. It is essential to inform the patient about the expected outcomes, but also the possible undesired outcomes. The pat...Medical treatment of patients inherently entails the risk of undesired complication or side effects. It is essential to inform the patient about the expected outcomes, but also the possible undesired outcomes. The patients preference and values regarding the potential outcomes should be involved in the decision making process. Even though many orthopaedic surgeons are positive towards shared decision-making, it is minimally introduced in the orthopaedic daily practice and decision-making is still mostly physician based. Decision aids are designed to support the physician and patient in the shareddecision-making process. By using decision aids, patients can learn more about their condition and treatment options in advance to the decision-making. This will reduce decisional conflict and improve participation and satisfaction.展开更多
文摘Objectives: To describe the communication behaviors of patients and physicians and patient par-ticipation in communication about treatment decision-making during consultation visits for local-ized prostate cancer (LPCa). Methods: This is a secondary analysis of data from 52 men enrolled in the usual care control group of a randomized trial that focused on decision-making for newly diagnosed men with LPCa. We analyzed the patient-physician communication using the transcribed audio-recordings of real-time treatment consultations and a researcher-developed coding tool, including codes for communication behaviors (information giving, seeking, and clarifying/ verifying) and contents of clinical consultations (health histories, survival/mortality, treatment options, treatment impact, and treatment preferences). After qualitative content analysis, we categorized patient participation in communication about treatment-related clinical content, including “none” (content not discussed);“low” (patient listening only);“moderate” (patient providing information or asking questions);and “high” (patient providing information and asking questions). Results: Physicians mainly provided information during treatment decision consultations and patients frequently were not active participants in communication. The participation of patients with low and moderate cancer risk typically was: 1) “moderate and high” in discussing health histories;2) “low” in discussing survival/mortality;3) “low and moderate” in discussing treatment options;4) “none and low” in discussing treatment impacts;and 5) “low” in discussing treatment preferences. Conclusions: Findings suggest opportunities for increasing patient participation in communication about treatment decision-making for LPCa during clinical consultations.
文摘Shared decision-making has been described as allowing patients to gain more control over their life situation and feel less helpless. The aim of this systematic review was to describe the involvement of older patients in shared decision-making in community settings. In accordance with the systematic review method, a total of 2468 abstracts were read, after which nine quantitative studies were included. A qualitative thematic analysis was performed and two themes emerged;increased understanding of self-management and a desire to strengthen one’s position in relationship with professionals, both of which were essential for empowering older patients to participate in shared decision-making. Older patients’ shared decision-making was seen as a struggle to maintain their autonomy in different areas of everyday life. Emotional and psychological problems made their position more difficult. In order to empower them in relationships with healthcare professionals, older patients require more knowledge (self-efficacy) and information about their illness, which could strengthen their position in the decision-making process. They also need a greater awareness of decisional conflicts that may arise. Age, gender and health status influence older patients’ chance of being respected and taken seriously in relationship with professionals.
文摘The simulated patient methodology(SPM)is considered the“gold standard”as covert participatory observation.SPM is attracting increasing interest for the investigation of community pharmacy practice;however,there is criticism that SPM can only show a small picture of everyday pharmacy practice and therefore has limited external validity.On the one hand,a certain design and application of the SPM goes hand in hand with an increase in external validity.Even if,on the other hand,this occurs at the expense of internal validity due to the trade-off situation,the justified criticism of the SPM for investigating community pharmacy practice can be countered.
文摘BACKGROUND There is a lack of studies and educational programs focused on biosimilars and shared decision-making among patients diagnosed with various rheumatic diseases.AIM To improve knowledge and awareness of biosimilars and shared decision-making among patients attending rheumatology practices in Colorado as well as to assess a rheumatology patient’s interest in discussing biosimilars as well as shared decision-making with others(e.g.,medical professionals,family members,friends).METHODS Our goal was to work with 80 rheumatology teams in Colorado.We developed and distributed 2000 multi-page brochures to each participating office and later conducted an online anonymous survey.RESULTS There were a total of 49(2.5%)rheumatology patients who responded to our survey.After reading our educational booklet,many survey respondents identified the correct answer in most questions focused on biosimilars or shared decision-making.Our survey results suggest that patients attending rheumatology practices in Colorado are generally not involved in discussions with their providers regarding treatment plans or options.The improvement in scores after reading our educational materials was statistically significant for biosimilars and shared decision-making.CONCLUSION Overall,the level of knowledge and awareness of biosimilars and shared decisionmaking among patients attending rheumatology practices in Colorado was low.More educational programs as well as follow up trainings to measure changes in knowledge and awareness regarding biosimilars and shared decision-making among patients attending rheumatology practices are recommended.
文摘This paper delves into the intricate interplay between artificial intelligence(AI)systems and the perpetuation of Anti-Black racism within the United States medical industry.Despite the promising potential of AI to enhance healthcare outcomes and reduce disparities,there is a growing concern that these technologies may inadvertently/advertently exacerbate existing racial inequalities.Focusing specifically on the experiences of Black patients,this research investigates how the following AI components:medical algorithms,machine learning,and natural learning processes are contributing to the unequal distribution of medical resources,diagnosis,and health care treatment of those classified as Black.Furthermore,this review employs a multidisciplinary approach,combining insights from computer science,medical ethics,and social justice theory to analyze the mechanisms through which AI systems may encode and reinforce racial biases.By dissecting the three primary components of AI,this paper aims to present a clear understanding of how these technologies work,how they intersect,and how they may inherently perpetuate harmful stereotypes resulting in negligent outcomes for Black patients.Furthermore,this paper explores the ethical implications of deploying AI in healthcare settings and calls for increased transparency,accountability,and diversity in the development and implementation of these technologies.Finally,it is important that I prefer the following paper with a clear and concise definition of what I refer to as Anti-Black racism throughout the text.Therefore,I assert the following:Anti-Black racism refers to prejudice,discrimination,or antagonism directed against individuals or communities of African descent based on their race.It involves the belief in the inherent superiority of one race over another and the systemic and institutional practices that perpetuate inequality and disadvantage for Black people.Furthermore,I proclaim that this form of racism can be manifested in various ways,such as unequal access to opportunities,resources,education,employment,and fair treatment within social,economic,and political systems.It is also pertinent to acknowledge that Anti-Black racism is deeply rooted in historical and societal structures throughout the U.S.borders and beyond,leading to systemic disadvantages and disparities that impact the well-being and life chances of Black individuals and communities.Addressing Anti-Black racism involves recognizing and challenging both individual attitudes and systemic structures that contribute to discrimination and inequality.Efforts to combat Anti-Black racism include promoting awareness,education,advocacy for policy changes,and fostering a culture of inclusivity and equality.
基金funding support from Himalayan Adaptation, Water and Resilience (HI-AWARE) Research Consortium
文摘The value-chain approach(VCA)was used for exploring how a niche crop,namely large cardamom(Amomum subulatum Roxb.),can be developed sustainably to increase incomes and enhance rural livelihoods in the mountains.Large cardamom is a high-value,agro-climatically suitable,and non-perishable spice crop grown in the Himalayan region.Originating in Sikkim,the crop is important to the local economy and is sold in both domestic and international markets;however,its production in India has been declining significantly in recent years.Using VCA and participatory methods of data collection the study helped elicit value chain actors’perspectives on various reasons for the decline as well as potential strategies to improve the cardamom value chain.The results present the multiple environmental and climatic(e.g.water stress),social(e.g.women participation)and institutional(e.g.lack of trust between actors)challenges and corresponding upgrading strategies.Through participatory multi-criteria analysis(MCA),the strategies were prioritized based on the overall preferences of multiple stakeholders.The analysis considered eight criteria and 25 options,or strategies,and found that that marketability and profitability were the most important criteria,and increasing cardamom production,the most important optiontrait.Stakeholder discussions along with sensitivity analysis also showed how these options could be implemented and revealed how criteria preferences can change with expert inputs.This combination of VCA and MCA,because it supports participatory decision-making and balances multiple dimensions of sustainable development,can be effectively deployed in planning for agricultural development in the mountains.
文摘目的探讨患者参与式全程营养管理对同期放化疗食管癌患者营养状态和毒副作用的影响。方法选择2021年2—7月在泰安市肿瘤防治院拟行同期放化疗的食管癌患者50例作为对照组,予以常规肿瘤患者营养指导;按照组间基本资料具有可比性的原则选择2021年8月—2022年2月在泰安市肿瘤防治院行同期放化疗的食管癌患者50例作为观察组,予以患者参与式全程营养管理;两组均持续干预8周,对比两组患者行护理管理前后的营养状态[营养风险筛查表(2002)(NRS-2002)、患者主观全面评估(Scored Patient-Generated Subjective Global Assessment,PG-SGA)及相关血清蛋白指标]、癌性疲乏度[癌症疲乏量表(CFS)]、饮食依从性及放化疗毒副作用发生率。结果患者参与式全程营养管理后,两组营养不良风险发生率比较差异无统计学意义(P>0.05);观察组PG-SGA评分低于对照组,血清蛋白各项指标水平均高于对照组(P<0.05);观察组CFS评分低于对照组,能量及蛋白质摄入依从性评分均高于对照组(P<0.05)。两组患者的毒副作用发生率比较差异无统计学意义(P>0.05)。结论患者参与式全程式营养管理模式可有效改善患者的营养状况和癌性疲乏,提高患者的饮食依从性。
文摘目的:探讨病人参与式护理下重组人表皮生长因子(recombinant human epidermal growth factor,rhEGF)结合银离子敷料治疗在降低骨折病人压力性损伤发生风险中的应用效果。方法:选取2021年1月—12月在我院治疗的198例骨折病人为研究对象,采取随机数字表法将其分为对照组和观察组,各99例。两组均给予rhEGF结合银离子敷料治疗,对照组给予常规护理,观察组在对照组的基础上给予病人参与式护理模式。比较两组压力性损伤发生率、临床疗效、炎症情况及病人护理参与行为。结果:干预2个月后,观察组压力性损伤发生率(5.05%)低于对照组(13.13%),压力性损伤临床疗效优于对照组;肿瘤坏死因子、血清超敏C反应蛋白、白细胞介素-6和白细胞介素-8炎症因子水平低于对照组;参与行为量表总分[(67.24±6.21)分]高于对照组[(54.23±4.82)分],差异均有统计学意义(P<0.05)。结论:病人参与式护理可提高骨折病人在压力性损伤护理中的参与度,降低病人压力性损伤发生风险,缓解炎症反应,促进创面愈合。
文摘In China,there are three basic clinical decision-making modes for patients,namely patients autonomous decision-making mode,family decision-making mode and patient and family codetermination.They were produced under the unique background of Chinese medicine,Confucian philosophy and law in China,l this paper,the concepts,advantages and disadvantages of these three decision-making modes were analyzed In addition,some suggestions were put forward for the improvement.The first is that we suggest to establis standards for choosing decision-making modes;the second is to further learn and publicize relevant laws;thirdly the legal system needs to be further refined;and the last one is to carry out ethical ward round.
文摘The application of main methodologies for clinical decision-making by residents in emergency medical practice was assessed,and issues in this area were investigated.The treatments provided to 2611 critical patients by the Emergency Department of Peking Union Medical College Hospital were analyzed by independent investigators who evaluated the main clinical decision-making processes applied by the hospital residents.The application of decision-making strategies by PG1 and PG3 groups,which means the residents in first year and the third year,were compared.The patients were treated according to pattern recognition(43.0%),hypotheticodeductive reasoning(23.4%),event-driven models(19.3%),and rule-using algorithms(5.9%).A significant difference was found between PG1 and PG3 groups(χ^(2)=498.01,P<0.001).Pattern recognition and hypotheticdeductive methods were the most common techniques applied by emergency physicians in evaluating critically ill patients.The decision-making processes applied by junior and senior residents were significantly different,although neither group adequately applied rule-using algorithms.Inclusion of clinical decision-making in medical curricula is needed to improve decision-making in critical care.
文摘Medical treatment of patients inherently entails the risk of undesired complication or side effects. It is essential to inform the patient about the expected outcomes, but also the possible undesired outcomes. The patients preference and values regarding the potential outcomes should be involved in the decision making process. Even though many orthopaedic surgeons are positive towards shared decision-making, it is minimally introduced in the orthopaedic daily practice and decision-making is still mostly physician based. Decision aids are designed to support the physician and patient in the shareddecision-making process. By using decision aids, patients can learn more about their condition and treatment options in advance to the decision-making. This will reduce decisional conflict and improve participation and satisfaction.